Table 1.

Clinical characteristics of patients from the COMPASS trial included in analysis.

CIBERSORT Cohort	All	mFFX	Gem-based	P-value
# Included	145	83	62
Age
Mean (SD)	62.7 (9.3)	60.0 (8.6)	66.0 (9.2)	<0.0001
Median [Min, Max]	64 [29, 84]	61 [35, 77]	67 [29, 84]
Gender (%)
M	81 (55.8)	54 (66.7)	27 (33.3)	0.0099
F	64 (44.2)	29 (45.3)	35 (54.7)
Disease Status (%)
Locally Advanced	20 (13.8)	16 (80.0)	4 (20.0)	0.0267
Metastatic	125 (86.2)	67 (53.6)	58 (46.4)
Biopsy Site (%)
Pancreas	46 (31.7)	25 (54.3)	21 (45.7)	0.6312
Liver	99 (68.3)	58 (58.6)	41 (41.4)
Therapy Response (%)
Responders	94	52	42	0.4820
Nonresponders	50	31	19

Bolded values are those with p-values below a cutoff of 0.05, suggesting significance.